Reoperation for persistant outflow obstruction in hypertrophic cardiomyopathy

This study compares results of a second left ventricular myotomy and myectomy (M + M) with those of mitral valve replacement (MVR) as reoperative procedures for persistent left ventricular outflow obstruction after M + M in hypertrophic cardiomyopathy. Comparison of the second M + M group (n = 12) with the MVR group (n = 11) disclosed significant differences (p < 0.05) in mean age at the initial operation (29 ± 11 years versus 40 ± 8 years), interval between operations (46 ± 57 months versus 18 ± 13 months), and age at reoperation (33 ± 10 years versus 42 ± 8 years); and insignificant differences in mean preoperative functional class, cardiac index, left ventricular outflow gradients at rest or with provocation, and hospital mortality at reoperation ( 2 12 versus 1 11). At 6 months after reoperation, comparison of results of a second M + M with MVR showed that mean functional class, cardiac index, and left ventricular outflow gradient at rest were similarly improved, but the outflow gradient with provocation was significantly higher in the second M + M group (57 ± 44 mm Hg versus 14 ± 9 mm Hg, p < 0.05). Total follow-up was 108 patient-years (100% complete) with an average of 5.9 years per patient in the second M + M group and 3.4 years per patient in the MVR group. Actuarial survival, including hospital mortality, at 3 and 5 years was 83% and 76%, respectively, after the second M + M, which was similar to 92% and 77% after MVR. Thus, either a second M + M or MVR is effective in relieving the hemodynamic obstruction and decreasing symptoms, but a second M - M is preferable because complications of anticoagulation and substitute valves are avoided.